NIKA HEALTH PRODUCTS LTD has a total of 222 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are ADVANCED MEDICINE RES INST, BAYHILL THERAPEUTICS INC and COMBINATORX.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 12 | |
#3 | EPO (European Patent Office) | 12 | |
#4 | Hungary | 12 | |
#5 | WIPO (World Intellectual Property Organization) | 11 | |
#6 | Canada | 10 | |
#7 | Norway | 10 | |
#8 | Poland | 10 | |
#9 | Bulgaria | 9 | |
#10 | Brazil | 9 | |
#11 | Hong Kong | 7 | |
#12 | African Intellectual Property Organization | 7 | |
#13 | South Africa | 7 | |
#14 | Czechia | 6 | |
#15 | Finland | 6 | |
#16 | Singapore | 6 | |
#17 | Slovakia | 6 | |
#18 | Latvia | 5 | |
#19 | New Zealand | 5 | |
#20 | China | 4 | |
#21 | Republic of Korea | 4 | |
#22 | Romania | 4 | |
#23 | Georgia | 3 | |
#24 | Israel | 3 | |
#25 | Mexico | 3 | |
#26 | Peru | 3 | |
#27 | Tunisia | 3 | |
#28 | Colombia | 2 | |
#29 | EAPO (Eurasian Patent Organization) | 2 | |
#30 | Lithuania | 2 | |
#31 | Morocco | 2 | |
#32 | Monaco | 2 | |
#33 | El Salvador | 2 | |
#34 | Yugoslavia (Serbia and Montenegro) | 2 | |
#35 | Argentina | 1 | |
#36 | Bosnia and Herzegovina | 1 | |
#37 | Czechoslovakia | 1 | |
#38 | Denmark | 1 | |
#39 | Algeria | 1 | |
#40 | Estonia | 1 | |
#41 | United Kingdom | 1 | |
#42 | Greece | 1 | |
#43 | Croatia | 1 | |
#44 | Indonesia | 1 | |
#45 | Jordan | 1 | |
#46 | Republic of Moldova | 1 | |
#47 | Malawi | 1 | |
#48 | Panama | 1 | |
#49 | Philippines | 1 | |
#50 | Taiwan | 1 | |
#51 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Unspecified technologies | |
#5 | Implantable devices | |
#6 | Object sterilising | |
#7 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Klein Peter | 83 |
#2 | Kiczka Witold | 77 |
#3 | Herrmann Peter | 35 |
#4 | Stozek Jolanta | 34 |
#5 | Religa Zbigniew | 33 |
#6 | Cichon Romuald | 33 |
#7 | Krzyskow Marek | 32 |
#8 | Stolarzewicz Bogdan | 30 |
#9 | Glueck Reinhard | 22 |
#10 | Gluck Reinhard | 19 |
Publication | Filing date | Title |
---|---|---|
CA2388053A1 | Cationic dosper virosomes | |
EP1174147A1 | Reversal of antibiotic resistance with lysozyme dimer | |
NZ504444A | Cationic virosomes as transfer system for genetic material useful in non-infectious gene therapy | |
US6183742B1 | Applications of lysozyme dimer | |
IL139209D0 | Lysozyme dimers and methods utilizing the same | |
US6123937A | Applications of lysozyme dimer | |
WO9741834A1 | Cationic virosomes as transfer system for genetic material | |
JO1898B1 | New applications of lysozme dimer | |
MX9705246A | New applications of lysozyme dimer. | |
DZ1964A1 | New applications of a lysozyme dimer. | |
ZA9600127B | Applications of lysozyme dimer | |
PL307413A1 | Novel application of a lysozyme dimer as a prophylactic agent and method of preparing a pharmaceutical composition of prophylactic effect and novel prophylactic agents obtained thereby | |
SG24694G | Use of lysozyme dimer and/or a ribonuclease dimer for the manufacture of an antiviral or antibiotic drug. | |
US5989880A | Method of preparing lysozyme dimers | |
GEP20012466B | Lysozyme Dimer and Compositions Containing the Same | |
PL307244A1 | Lysozyme dimer as well as composition containing it. novel application of lysozyme dimer and compositions containing it | |
PL295273A1 | Method of obtaining a preparation capable to retard the synthesis of endogenous cytotoxic cytokinins | |
SK122893A3 | Support for a heart valve prosthesis | |
AU666304B2 | Process and apparatus for the production of a heart valve prosthesis | |
HU9900125D0 | Synthetic membrane vesicles as vehicles containing functionally active fusional peptides and pharmaceutical compositions comprising them |